Monster Beverage (MNST) PT Raised to $92 at Stifel

Stifel analyst Matt Smith raised the price target on Monster Beverage (NASDAQ: MNST) to $92.00 (from $82.00) while maintaining a Buy rating.

The analyst comments "Monster reported solid 4Q25 results with sales above consensus and gross margin expansion across the business. Revenue was up 16% on an underlying basis, accelerating sequentially, with ~13% growth in the U.S. and 23% growth in International. Sales momentum continued in January with 21% growth and 26% when adjusted for an extra selling day. Gross margin expanded 20bps in the quarter driven by pricing actions, supply chain optimization and product sales mix partially offset by can costs and geographic sales mix. We are slightly raising our estimates to reflect stronger consumption trends and better margin performance in 2H26. We continue with our Buy rating and raise our target price to $92. Company growth through 2026 is expected to be driven by innovation, pricing actions and maintaining the core portfolio. We would be buyers on weakness tomorrow, the top-line growth is differentiated and durable, margins to improve in 2H26."

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
• UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)